Skip to main content

Periodontal Disease

2
Pipeline Programs
5
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

BioTherapeutics Inc
BioTherapeutics IncVA - Blacksburg
1 program
1
ST266Phase 21 trial
Active Trials
NCT02761993Completed151Est. Oct 2017
Noveome Biotherapeutics
1 program
1
ST266Phase 2
Sanofi
SanofiPARIS, France
1 program
Investigational ProcedureN/A2 trials
Active Trials
NCT07536048Not Yet Recruiting100Est. May 2027
NCT06582056Completed226Est. Sep 2025
Johnson & Johnson
Johnson & JohnsonNEW BRUNSWICK, NJ
1 program
Periodontal and Periapical Inflammation and PregnancyN/A1 trial
Active Trials
NCT00490165Completed30Est. Dec 2011
Biocorp
BiocorpFrance - Issoire
1 program
trochesN/A1 trial
Active Trials
NCT04873505Completed50Est. Apr 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
BioTherapeutics IncST266
SanofiInvestigational Procedure
SanofiInvestigational Procedure
Biocorptroches
Johnson & JohnsonPeriodontal and Periapical Inflammation and Pregnancy

Clinical Trials (5)

Total enrollment: 557 patients across 5 trials

Safety, Efficacy and Treatment Regimen Study of ST266 in Subjects With Moderate to Severe Periodontitis

Start: Apr 2016Est. completion: Oct 2017151 patients
Phase 2Completed
NCT07536048SanofiInvestigational Procedure

A Longitudinal Study of Epstein-Barr Virus (EBV) Reactivation in Adults Aged 18 to 29 Years

Start: Apr 2026Est. completion: May 2027100 patients
N/ANot Yet Recruiting
NCT06582056SanofiInvestigational Procedure

Study on Biomarkers of Periodontitis and Type 2 Diabetes Mellitus in Males and Females 30 - 70 Years of Age

Start: Oct 2024Est. completion: Sep 2025226 patients
N/ACompleted

Functional Validation of Lactobacillus Containing Oral Tablet

Start: Oct 2020Est. completion: Apr 202250 patients
N/ACompleted
NCT00490165Johnson & JohnsonPeriodontal and Periapical Inflammation and Pregnancy

Periodontal and Periapical Inflammation and Pregnancy

Start: Mar 2007Est. completion: Dec 201130 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.